Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.

Auteurs

Q. Laurent-Badr, C. Barbe, M. Brugel, V. Hautefeuille, J. Volet, S. Grelet, E. Desot, D. Botsen, S. Deguelte, A. Pitta, N. Abdelli, M. Brasseur, L. De Mestier, C. Neuzillet, O. Bouché